Sutezolid

N/A

Report date: 2023/01/18 20:00:35
NME

Base Information

Drug NameSutezolid
Drug Alias Name舒特唑利德sutezolid舒替唑烷sutezolidum苏特唑利 +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBotswanaUnited StatesVietnam +[17] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesSequella IncNational Institute Of Allergy And Infectious Diseases (Niaid)The Aurum Institute
Inactive CompaniesBill & Melinda Gates Medical Research Institute
Active IndicationsTuberculosis, PulmonaryTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG